← Eichor
Condition: Retinoblastoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Retinoblastoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Topotecan and Melphalan for Retinoblastoma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT04799002Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biologica
Phase N/A · 5 location(s) · National Cancer Institute (NCI) · NCT01109394Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Phase 1 · 10 location(s) · Circle Pharma · NCT06577987Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
EARLY_Phase 1 · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT06424301Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma
Phase N/A · 7 location(s) · French Africa Pediatric Oncology Group · NCT04425434Retinoblastoma Patient Clinical Database and Tissue Repository
Phase N/A · 9 location(s) · Children's Hospital Los Angeles · NCT04959097Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tis
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06498648Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268Molecular Analysis Of Solid Tumors
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT01050296Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT03546387GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
Phase 1 · 1 location(s) · Stephan Grupp MD PhD · NCT05650749Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma
NA · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT04903678Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC
Phase N/A · 1 location(s) · Fudan University · NCT06369181Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Phase N/A · 11 location(s) · Vanderbilt-Ingram Cancer Center · NCT03932786Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-
Phase N/A · 1 location(s) · University of Washington · NCT06725173A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Phase 2 · 20 location(s) · Children's Oncology Group · NCT05504291Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT03267459Trilateral Retinoblastoma: Incidence and Outcomes
Phase N/A · 1 location(s) · Amsterdam UMC, location VUmc · NCT06367530Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Phase 2 · 4 location(s) · Medical College of Wisconsin · NCT04040205High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
EARLY_Phase 1 · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT06972602Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT05080010Retinoblastoma Phase II Expanded Access Clinical Trial
Phase 2 · 2 location(s) · Targeted Therapy Technologies, LLC · NCT06679634Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome
Phase 2/Phase 3 · 28 location(s) · Institut Curie · NCT04681417
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.